MEMPHIS, Tenn. (WMC) - St. Jude and UTHSC have started recruiting adults ages 18 and older, in the Memphis area, for phase 3 of a clinical research study to evaluate a possible COVID-19 vaccine.
St. Jude Children’s Research Hospital and the University of Tennessee Health Science Center will offer a testing site for phase 3 of the Janssen Pharmaceutical Companies of Johnson & Johnson clinical trial, according to a press release.
This particular phase is to evaluate the safety and effectiveness of a single dose of the Janssen COVID-19 vaccine candidate in adults, with emphasis put on representation from people older than 60. The CDC has identified older individuals as part of the high-risk groups, or people who are more vulnerable to the effects of the virus.
More information about the trial can be found here: https://www.stjude.org/media-resources/news-releases/.